Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
NSE India S.E.
07:05:09 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 1,407.80 INR | -1.77% |
|
-3.66% | -22.25% |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 200,521 | 168,871 | 161,438 | - | - |
| Change | - | -15.78% | -4.4% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 170,294 | 162,602 | 161,438 |
| Change | - | -9.93% | -5.71% | -4.52% | -0.72% |
| P/E | -1,075x | -229x | 34.8x | 16.8x | - |
| PBR | - | - | 2.57x | 2.27x | 2.22x |
| PEG | - | -1x | -0x | 0x | - |
| Capitalization / Revenue | - | 11.9x | 7.41x | 4.75x | 5.42x |
| EV / Revenue | - | 12.7x | 7.81x | 4.78x | 5.42x |
| EV / EBITDA | - | 59.4x | 21.6x | 11.9x | 14x |
| EV / EBIT | - | 719x | 30.8x | 15.8x | 19.1x |
| EV / FCF | - | -32.2x | 30.8x | 21.7x | 20.9x |
| FCF Yield | - | -3.1% | 3.25% | 4.61% | 4.79% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 40.5 | 83.73 | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 14,216 | 21,798 | 34,019 | 29,769 |
| EBITDA 1 | - | 3,042 | 7,875 | 13,689 | 11,544 |
| EBIT 1 | - | 251.3 | 5,526 | 10,322 | 8,472 |
| Net income 1 | -179.7 | -738 | 4,459 | 8,968 | 7,308 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 | - |
| Reference price 2 | 1,752.25 | 1,473.30 | 1,407.80 | 1,407.80 | 1,407.80 |
| Nbr of stocks (in thousands) | 114,436 | 114,621 | 114,674 | - | - |
| Announcement Date | 5/5/25 | 5/13/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.76x | 7.81x | 21.62x | - | 1.7B | |
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | |
| Average | 26.97x | 24.69x | 15.95x | 0.32% | 37.41B | |
| Weighted average by Cap. | 26.01x | 24.93x | 15.51x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
